Literature DB >> 20542028

Hsp105 reduces the protein aggregation and cytotoxicity by expanded-polyglutamine proteins through the induction of Hsp70.

Nobuyuki Yamagishi1, Kazumasa Goto, Satomi Nakagawa, Youhei Saito, Takumi Hatayama.   

Abstract

Hsp105alpha and Hsp105beta are major heat shock proteins in mammalian cells and belong to the HSP105/110 family. Hsp105alpha is expressed constitutively in the cytoplasm of cells, while Hsp105beta, an alternatively spliced form of Hsp105alpha, is expressed specifically in the nucleus of cells during mild heat shock. Here, we show that not only Hsp105beta but also Hsp105alpha accumulated in the nucleus of cells following the expression of enhanced green fluorescent protein with a pathological length polyQ tract (EGFP-polyQ97) and suppressed the intranuclear aggregation of polyQ proteins and apoptosis induced by EGFP-polyQ97. Mutants of Hsp105alpha and Hsp105beta with changes in the nuclear localization signal sequences, which localized exclusively in the cytoplasm with or without the expression of EGFP-polyQ97, did not suppress the intranuclear aggregation of polyQ proteins and apoptosis induced by EGFP-polyQ97. Furthermore, Hsp70 was induced by the co-expression of Hsp105alpha and EGFP-polyQ97, and the knockdown of Hsp70 reduced the inhibitory effect of Hsp105alpha and Hsp105beta on the intranuclear aggregation of polyQ proteins and apoptosis induced by EGFP-polyQ97. These observations suggested that Hsp105alpha and Hsp105beta suppressed the expanded polyQ tract-induced protein aggregation and apoptosis through the induction of Hsp70. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20542028     DOI: 10.1016/j.yexcr.2010.06.003

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Human heat shock protein 105/110 kDa (Hsp105/110) regulates biogenesis and quality control of misfolded cystic fibrosis transmembrane conductance regulator at multiple levels.

Authors:  Anita Saxena; Yeshavanth K Banasavadi-Siddegowda; Yifei Fan; Sumit Bhattacharya; Gargi Roy; David R Giovannucci; Raymond A Frizzell; Xiaodong Wang
Journal:  J Biol Chem       Date:  2012-04-13       Impact factor: 5.157

Review 2.  High molecular weight stress proteins: Identification, cloning and utilisation in cancer immunotherapy.

Authors:  Xiang-Yang Wang; John R Subjeck
Journal:  Int J Hyperthermia       Date:  2013-07-05       Impact factor: 3.914

Review 3.  Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson's disease.

Authors:  Sandeep K Sharma; Smriti Priya
Journal:  Cell Mol Life Sci       Date:  2016-08-13       Impact factor: 9.261

4.  Sympatric speciation of spiny mice, Acomys, unfolded transcriptomically at Evolution Canyon, Israel.

Authors:  Kexin Li; Huihua Wang; Zhenyuan Cai; Liuyang Wang; Qinqin Xu; Matěj Lövy; Zhenlong Wang; Eviatar Nevo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-01       Impact factor: 11.205

5.  Chaperone-like activity of high-mobility group box 1 protein and its role in reducing the formation of polyglutamine aggregates.

Authors:  Hyun Jin Min; Eun Ae Ko; Jie Wu; Eun Sung Kim; Min Kyung Kwon; Man Sup Kwak; Ji Eun Choi; Jong Eun Lee; Jeon-Soo Shin
Journal:  J Immunol       Date:  2013-01-09       Impact factor: 5.422

Review 6.  Protein Quality Control by Molecular Chaperones in Neurodegeneration.

Authors:  Aaron Ciechanover; Yong Tae Kwon
Journal:  Front Neurosci       Date:  2017-04-06       Impact factor: 4.677

7.  XBP1 signalling is essential for alleviating mutant protein aggregation in ER-stress related skeletal disease.

Authors:  Katarzyna A Piróg; Ella P Dennis; Claire L Hartley; Robert M Jackson; Jamie Soul; Jean-Marc Schwartz; John F Bateman; Raymond P Boot-Handford; Michael D Briggs
Journal:  PLoS Genet       Date:  2019-07-01       Impact factor: 5.917

8.  Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy.

Authors:  Bilal Malik; Niranjanan Nirmalananthan; Anna L Gray; Albert R La Spada; Michael G Hanna; Linda Greensmith
Journal:  Brain       Date:  2013-02-07       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.